{
  "cik": 1794546,
  "cik_padded": "0001794546",
  "entityName": "CARLSMED, INC.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-071551",
      "filed": "2026-02-25",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 642000.0,
        "cash": 85793000.0,
        "cost_of_revenue": 12471000.0,
        "eps_diluted": -2.12,
        "free_cash_flow": -29619000.0,
        "gross_profit": 38040000.0,
        "net_income": -29634000.0,
        "operating_cash_flow": -28977000.0,
        "operating_income": -30574000.0,
        "revenue": 50511000.0,
        "stockholders_equity": 98869000.0,
        "total_assets": 130120000.0,
        "total_liabilities": 31251000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "gross_margin": 0.7531032844330938,
        "leverage": 0.3160849204502928,
        "net_margin": -0.5866840886143613,
        "operating_margin": -0.6052938963790065,
        "revenue_growth_yoy": 0.8594146880176698,
        "roa_avg2y": -0.32574858198126894,
        "roa_period_end": -0.2277436212726714,
        "roe_avg2y": -2.0987995325613515,
        "roe_period_end": -0.2997299456857053
      }
    },
    {
      "accn": "0001193125-26-071551",
      "filed": "2026-02-25",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 180000.0,
        "cash": 40125000.0,
        "cost_of_revenue": 7117000.0,
        "eps_diluted": -6.11,
        "free_cash_flow": -25646000.0,
        "gross_profit": 20048000.0,
        "net_income": -24257000.0,
        "operating_cash_flow": -25466000.0,
        "operating_income": -24122000.0,
        "revenue": 27165000.0,
        "stockholders_equity": -70630000.0,
        "total_assets": 51824000.0,
        "total_liabilities": 26228000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "gross_margin": 0.7380084667771029,
        "net_margin": -0.8929504877599854,
        "operating_margin": -0.8879808577213326,
        "roa_period_end": -0.46806498919419576,
        "roe_avg2y": 0.4155018842069202
      }
    },
    {
      "accn": "0001193125-26-071551",
      "filed": "2026-02-25",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "cash": 7222000.0,
        "stockholders_equity": -46130000.0
      },
      "period_end": "2023-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-071551",
    "filed": "2026-02-25",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "3841",
  "sic_description": "Surgical & Medical Instruments & Apparatus",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001794546.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001794546.json"
  },
  "ticker": "CARL"
}